Expectedly, monocytes migrated toward the chemokines CCL2, CCL5, and CX3CL1, with a higher migratory activity observed for monocytes from MS patients compared to healthy individuals (Figures 6B–D). This evidence concerns the gene CCL2 and myeloid sarcoma.